None listed
Conditions
Interventions
Intervention1: Turcuron: oral administration of a single dose of 400 mg Turcuron capsule for one day
Control Intervention1: Placebo: oral administration of a single dose of 400 mg placebo capsule for
Sponsors
Vidya Herbs P Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1 Should have experienced at least one hangover previously. 2 Subjects with full comprehension and ability to understand the purpose and the nature of trial 3 Should be a non-smoker. 4 Should have no history of Alcoholic abuse i. Score of 5 Subjects with normal sleep patterns and habits. 6 Subject willing to adhere with their routine food habits, social drinking patterns and exercise regimen throughout the study 7 Must be willing and able to give informed consent and comply with the study procedures.
Exclusion criteria
Exclusion criteria: 1 History of drug dependence or excessive alcohol intake on a habitual basis of more than two units of alcoholic beverages. 2 Subjects with history of Psychiatric disorders, Seizures,Uncontrolled / serious medical illness including diabetes, liver disease, hypertension, Cardiac Disease/Neurological Problems, Gastrointestinal tract bleeding / peptic ulcer disease 3 Subjects on medications which prohibits alcohol consumption (drug interactions/contraindications). 4 Subjects who will require consumption of analgesic medications during the study. 5 Subjects who maybe allergic to any of the natural constituents of the Investigational Product. 6 History of clinically significant illness or any other medical disorder that may interfere with subject treatment, assessment or compliance with the protocol. 7 Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the alcohol hangover severity scale scoreTimepoint: Visit 2, Visit 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Questionnaire based assessmentsTimepoint: Visit 2, Visit 3;Changes in Serum and Urine MarkersTimepoint: Visit 2, Visit 3 | — |
Countries
India
Contacts
Public ContactJestin V Thomas
Leads Clinical Research and Bio Services Private Limited
Outcome results
None listed